These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26720726)

  • 1. Synthetic prions with novel strain-specified properties.
    Moda F; Le TN; Aulić S; Bistaffa E; Campagnani I; Virgilio T; Indaco A; Palamara L; Andréoletti O; Tagliavini F; Legname G
    PLoS Pathog; 2015 Dec; 11(12):e1005354. PubMed ID: 26720726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prion Concept and Synthetic Prions.
    Legname G; Moda F
    Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into alternate aggregated prion protein forms.
    Polano M; Bek A; Benetti F; Lazzarino M; Legname G
    J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-sensitive synthetic prions.
    Colby DW; Wain R; Baskakov IV; Legname G; Palmer CG; Nguyen HO; Lemus A; Cohen FE; DeArmond SJ; Prusiner SB
    PLoS Pathog; 2010 Jan; 6(1):e1000736. PubMed ID: 20107515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seeding specificity and ultrastructural characteristics of infectious recombinant prions.
    Piro JR; Wang F; Walsh DJ; Rees JR; Ma J; Supattapone S
    Biochemistry; 2011 Aug; 50(33):7111-6. PubMed ID: 21776987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
    Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
    Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic mammalian prions.
    Legname G; Baskakov IV; Nguyen HO; Riesner D; Cohen FE; DeArmond SJ; Prusiner SB
    Science; 2004 Jul; 305(5684):673-6. PubMed ID: 15286374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Prion Selection and Adaptation.
    Bistaffa E; Moda F; Virgilio T; Campagnani I; De Luca CMG; Rossi M; Salzano G; Giaccone G; Tagliavini F; Legname G
    Mol Neurobiol; 2019 Apr; 56(4):2978-2989. PubMed ID: 30074230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two alternative pathways for generating transmissible prion disease de novo.
    Makarava N; Savtchenko R; Baskakov IV
    Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cofactors influence the biological properties of infectious recombinant prions.
    Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
    Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids.
    Deleault NR; Piro JR; Walsh DJ; Wang F; Ma J; Geoghegan JC; Supattapone S
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8546-51. PubMed ID: 22586108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.
    Sano K; Atarashi R; Ishibashi D; Nakagaki T; Satoh K; Nishida N
    J Virol; 2014 Oct; 88(20):11791-801. PubMed ID: 25078700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated forms of the prion protein PrP demonstrate the need for complexity in prion structure.
    Wan W; Stöhr J; Kendall A; Stubbs G
    Prion; 2015; 9(5):333-8. PubMed ID: 26325658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
    Jones EM; Surewicz WK
    Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.